Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Jewish 100, 2014: Ephrat Levy-Lahad – Innovation and Activism
×
Error: Contact form not found.
by Algemeiner Staff
Ephrat Levy-Lahad. Photo: Breast Cancer Research Foundation.
Ephrat Levy-Lahad
Medical researcher
All women of Ashkenazi origin should be screened for two breast-cancer predisposition genes from the age of 30, said Prof. Ephrat Levy-Lahad, the head of a leading research team at Shaare Zedek Medical Center. Levy-Lahad’s 2014 announcement, which received international attention, was a departure from the previous guideline of testing for the two BRCA genes only if a close blood relative contracted breast or ovarian cancer. The finding will likely change screening practices in Israel and in Jewish communities worldwide, ultimately saving lives.
